Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Device Uses Electrical Stimulation to Control Snoring

Device Uses Electrical Stimulation to Control Snoring News & Analysis News From the Food and Drug Administration CAR-T Therapy Is Approved function has been authorized to help adults Helping Manufacturers Navigate for Non-Hodgkin Lymphoma reduce snoring and mild obstructive sleep Novel Coronavirus Variants The FDA is developing guidance for manu- A cell-based gene therapy to treat adults apnea (OSA). facturers of diagnostics, therapeutics, and with large B-cell lymphoma (LBCL) has re- The device, eXciteOSA, delivers a series vaccines to aid their response to emerging ceived FDA approval. Lisocabtagene of electrical pulses through a silicone severe acute respiratory syndrome coro- maraleucel, marketed as Breyanzi, is a chi- mouthpiece that sits around the tongue, mericantigenreceptorT-cell(CAR-T)therapy with 2 electrodes above the tongue and 2 navirus 2 variants, Acting Commissioner Janet Woodcock, MD, said in a statement. indicated for patients who haven’t re- below. Patients use the device for 20 min- Woodcock said FDA officials don’t sponded to or have relapsed after at least 2 utes once a day for 6 weeks, and once believe they’ll have to “start at square other systemic treatments. weekly thereafter. one with any of these products—we recog- In addition to diffuse LBCL—the most nize we are in a pandemic and we need to common http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA American Medical Association

Device Uses Electrical Stimulation to Control Snoring

Jaklevic, Mary Chris
JAMA , Volume 325 (11) – Mar 16, 2021
Download PDF
1 page

Device Uses Electrical Stimulation to Control Snoring

Abstract

News & Analysis News From the Food and Drug Administration CAR-T Therapy Is Approved function has been authorized to help adults Helping Manufacturers Navigate for Non-Hodgkin Lymphoma reduce snoring and mild obstructive sleep Novel Coronavirus Variants The FDA is developing guidance for manu- A cell-based gene therapy to treat adults apnea (OSA). facturers of diagnostics, therapeutics, and with large B-cell lymphoma (LBCL) has re- The device, eXciteOSA, delivers a series vaccines to aid...
Loading next page...
 
/lp/american-medical-association/device-uses-electrical-stimulation-to-control-snoring-bZzDu0lYff

References (0)

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
American Medical Association
Copyright
Copyright 2021 American Medical Association. All Rights Reserved.
ISSN
0098-7484
eISSN
1538-3598
DOI
10.1001/jama.2021.2622
Publisher site
See Article on Publisher Site

Abstract

News & Analysis News From the Food and Drug Administration CAR-T Therapy Is Approved function has been authorized to help adults Helping Manufacturers Navigate for Non-Hodgkin Lymphoma reduce snoring and mild obstructive sleep Novel Coronavirus Variants The FDA is developing guidance for manu- A cell-based gene therapy to treat adults apnea (OSA). facturers of diagnostics, therapeutics, and with large B-cell lymphoma (LBCL) has re- The device, eXciteOSA, delivers a series vaccines to aid their response to emerging ceived FDA approval. Lisocabtagene of electrical pulses through a silicone severe acute respiratory syndrome coro- maraleucel, marketed as Breyanzi, is a chi- mouthpiece that sits around the tongue, mericantigenreceptorT-cell(CAR-T)therapy with 2 electrodes above the tongue and 2 navirus 2 variants, Acting Commissioner Janet Woodcock, MD, said in a statement. indicated for patients who haven’t re- below. Patients use the device for 20 min- Woodcock said FDA officials don’t sponded to or have relapsed after at least 2 utes once a day for 6 weeks, and once believe they’ll have to “start at square other systemic treatments. weekly thereafter. one with any of these products—we recog- In addition to diffuse LBCL—the most nize we are in a pandemic and we need to common

Journal

JAMA – American Medical Association

Published: Mar 16, 2021

There are no references for this article.